• Medicina · Jan 2023

    [Mortality predictors in patients with native valve infective endocarditis].

    • Mercedes Pérez Ponsa, Rodrigo Bagnati, Santiago Decotto, Rocío Blanco, Florencia Parcerisa, Corina Nemirovsky, Alberto Domenech, Emiliano Rossi, and Rodolfo Pizarro.
    • Servicio de Cardiología, Hospital Italiano de Buenos Aires, Argentina. E-mail: mercedes.perez@hospitalitaliano.org.ar.
    • Medicina (B Aires). 2023 Jan 1; 83 (5): 753761753-761.

    IntroductionMortality of infective endocarditis (IE) in Argentina continues to be high. The aim objective was to describe the clinical characteristics and identify factors associated with in-hospital and long-term mortality in patients with native valve IE.MethodsRetrospective cohort study including adult patients with diagnosis of native valve IE, hospitalized during 2011-2021.ResultsA total of 129 patients with a mean age of 66±17 years were included. The most frequent responsible organism was Staphylococcus aureus (SA) (38.8%). Surgical indication criteria were present in 63.6% of the patients. Mortality during hospitalization was 22.5% .In the multivariate analysis that included Charlson comorbidity index, SA infection and the presence of surgical indication criteria, an adjusted OR of mortality of 1.32 (95%CI 1.10-1.57; p = 0.003), 2.75 (95%CI 1.11-6.8; p = 0.028) and 4.14 (95%CI 1.34-12; p = 0.013), respectively, was observed. In the multivariate analysis for long term mortality, that added surgical indication criteria and the performance of surgery during hospitalization, an adjusted OR of 1.62 (CI95% 1.31-2.00; p<001), 0.77 (95%CI 0.31-1.93; p = 0.58), 7.49 (95%CI 2.07-27.07; p = 0.002) and 0.21 (95%CI 0.06-0.70; p = 0.01), respectively, was observed.ConclusionsMortality in IE was associated with the degree of previous comorbidity, with the presence of surgical indication criteria and, inversely, with the timely completion of surgical treatment.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.